Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -0.88% | 725.44 | 2.6% | $748.08m | |
| AMGN | Amgen, Inc. | -0.25% | 230.36 | 1.4% | $606.98m | |
| BIIB | Biogen, Inc. | -0.74% | 260.33 | 1.8% | $575.78m | |
| MRNA | Moderna, Inc. | -4.13% | 119.99 | 0.0% | $565.61m | |
| GILD | Gilead Sciences, Inc. | -0.49% | 64.63 | 1.0% | $547.34m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.11% | 295.32 | 1.9% | $425.16m | |
| ILMN | Illumina, Inc. | -2.77% | 206.82 | 3.2% | $399.44m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1.49% | 4.08 | 0.7% | $285.21m | |
| SAVA | Cassava Sciences, Inc. | -5.60% | 39.98 | 0.0% | $179.07m | |
| BNTX | BioNTech SE | -1.38% | 135.63 | 0.0% | $107.89m | |
| TECH | Bio-Techne Corp. | -4.37% | 295.56 | 4.5% | $96.36m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -3.46% | 88.32 | 4.2% | $92.61m | |
| PRTA | Prothena Corp. Plc | -2.70% | 56.99 | 13.8% | $77.08m | |
| CRSP | CRISPR Therapeutics AG | -4.39% | 62.40 | 0.6% | $74.79m | |
| NVAX | Novavax, Inc. | -8.91% | 16.47 | 75.6% | $72.41m |
Company Profile
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The firm focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.